Whole blood RNA signatures in tuberculosis patients receiving H56:IC31 vaccine as adjunctive therapy.

Saved in:
Bibliographic Details
Title: Whole blood RNA signatures in tuberculosis patients receiving H56:IC31 vaccine as adjunctive therapy.
Authors: Alonso-Rodríguez N; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway., Vianello E; Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., van Veen S; Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Jenum S; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway., Tonby K; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., van Riessen R; Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Lai X; Oslo Centre for Biostatistics and Epidemiology, Faculty of Medicine, University of Oslo, Oslo, Norway., Mortensen R; Deptartment of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark., Ottenhoff THM; Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Dyrhol-Riise AM; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Source: Frontiers in immunology [Front Immunol] 2024 Feb 16; Vol. 15, pp. 1350593. Date of Electronic Publication: 2024 Feb 16 (Print Publication: 2024).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2024.1350593